List view / Grid view

Artificial Intelligence

 

article

New tRNA tech aims to rewrite rare disease treatment

9 June 2025 | By

Alltrna is redefining the future of rare disease treatment with engineered tRNA therapeutics that target genetic mutations - not just individual diseases. CEO Michelle Werner shares how this bold, mutation-driven approach could unlock universal treatments for thousands of patients long overlooked by traditional medicine.

whitepaper

Beyond the Lab: Clinical Trials

29 April 2025 | By

Explore how artificial intelligence (AI), biomarkers, and innovative trial technologies are creating a more efficient, data-driven future for drug discovery. From better patient selection to smarter trial design, see how clinical research is evolving to deliver new therapies faster.